About Us
EN
ENCN
Annals of OncologyJournal Home
Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting. With a large international editorial board of experts who are leaders in their fields, Annals of Oncology aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.
Publishing Model：
ISSN：0923-7534
|EISSN：1569-8041
|Publication Frequency：12 times a year
|Last updated on 01 May 2026 / Current volume： 杚篫 / Current issue： 逦
More Details
Oncology
Impact Factor
Journal Impact Factor(JIF) 2024
炆逦.鋺
Journal Citation Indicator(JCI) 2024
躭.杚躭
Web of Science Rank 2024:
鵣沟。鵣欄鵣佥巨
# 鋺/杚缗炆
98.93%
Q1
CiteScore Metrics
CiteScore 2024
篫蔡.鋺
=
缗炆躭杚鋺 Citation （2022-2024）
杚躭声 Article （2022-2024）
CiteScore Rank 2024
鵣鵃桧肃⻊肃茡续
# 鋺/鋺声逦
99.04%
Q1
㡶蠹陱囹锆肃⻊肃茡续
# 缗/声鋺缗
98.59%
Q1
